This CME-accredited OncoBlast activity uses case-based, ABIM-style questions to reinforce evidence-based clinical decision-making in gastrointestinal cancers. Participants will explore key advances in treatment selection and sequencing, biomarker-driven therapy, and evolving standards of care in GI malignancies. The interactive format is designed to challenge clinicians to synthesize clinical data, patient factors, and guideline recommendations in real-world scenarios.
Course Accreditations
Course Summary
| Events Starts | Events Ends |
|---|---|
| 1/1/2025 | 12/31/2025 |
- Medical oncologists
- Radiation oncologists
- Surgical oncologists
- Oncology residents/fellows
- Oncology NPs/PAs
- Oncology pharmacists
- Oncology nurses
Target Audience
- Apply recent clinical trial data to personalize neoadjuvant and adjuvant strategies in colorectal and rectal cancer.
- Integrate molecular profiling and biomarker-driven treatment selection in advanced GI cancers.
- Evaluate therapeutic options and sequencing for metastatic GI malignancies based on efficacy, safety, and patient-specific factors.
Learning Objectives
Upon successful completion of this educational activity, participants will be able to: